Newsbenzinga
Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why
· Published
Article summary
Crinetics Pharmaceuticals shares are trading higher in Monday's after-hours session after the company announced it will be acquired by Vertex.
An excerpt from the original article.
Comments —
Loading comments…